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percutaneous Nephrolithotomy: Current Methods and the Henry Ford
Hospital Experience
P.C. Shetty, MD,* Rajinder P. Sharma, MD,* Raymond H. Littleton, MD,+ Gary A. Krasicky, MD,+
jviatthew W. Burke, MD,* Brian J. Miles, MD,t James H. Thrall, MD,* and Joseph C. Cerny, MD+
Jhe combined radiologic!urologic approach to percutaneous
f-ena/ stone extraction has been practiced at Henry Ford
Hospital since November of 1982. This article descr/bes the
current methodology and reviews our experience in perform-

ing 121 percutaneous nephrolithotomies (PCNL). We conclude that PCNL is a safe, reliable, and cost-effective alternative to open nephrolithotomy in most padents.

Percutaneous nephrolithotomy provides access to the upper urinary tract as the urethra provides access to the bladder. First demonstrated by Goodwin in 1955, percutaneous
nephrostomy has become a safe and effective method of
urinary diversion. Our experience with more than 300 percutaneous nephrostomies has helped us to extend this technique to percutaneous nephrolithotomy and renal stone extraction from the upper collecting system. Since its early
description by Fernstrom and Johansson (1), percutaneous
nephrolithotomy (PCNL) has become a popular alternative
to surgical removal of renal calculi.

through a posterior calyx or infundibulum is preferred to
minimize the angle of entry in the renal pelvis. After confirming the position of the needle tip within the collecting system, a J guidewire (0.035 inch in length) is advanced into
the periphery ofthe collecting system. Serial dilatation ofthe
nephrostomy tract is performed over this guidewire with 7-,
9-, and 12-F Teflon dilators. Using a headhunter or cobra
catheter, a floppy-tipped guidewire (0.035 inch in length)
is directed down the ureter. The tip of the catheter is left in
the distal ureter or, preferably, coiled in the bladder.

Current Methods
The patient receives meperidine (0.4 mg, intramuscular injection) before the procedure is started, and endoscopic
retrograde ureteral stent placement is performed in the
urologic clinic. One percent lidocaine with epinephrine is
given, supplemented by intravenous administration of sedative as needed for the remainder of the procedure, which
is performed in a radiology suite (Fig 1) equipped with a highresolution, C-arm fluoroscopic device. Vital signs, including
EKG and depth of sedation are monitored by a nurse
anesthetist.
A specially designed sterile draping and fluid-collecting system is used to prevent contamination of the sterile field and
protect the fluoroscopic equipment (Fig 2). A preliminary
(scout) radiograph is obtained before the intrarenal collec''ng system is opacified. Contrast agent is injected via the
previously placed retrograde ureteric stent. These steps con'rm the position of the stone before selection of the
nephrostomy site. Opacification of the upper collecting sys^ can also be achieved using percutaneous thin-needle
^'^tegrade pyelography if placement ofthe ureteric stent was
unsuccessful.

Early in our experience, an 8-F Teflon catheter (without the
hub) was advanced over this anchor wire. Serial dilatation
of the tract was performed over the catheter-wire system using Amplatz Teflon dilators, and a 30-F sheath was left in
place. Using high-pressure tract-dilatation balloon catheters,
it is possible to dilate the nephrostomy tract from 9- to 30-F
in one step (2), which reduces patient discomfort, bleeding,
and radiation exposure, as well as the time required to perform the procedure (Fig 3). By preloading the 30-F Teflon
sheath (without a dilator) over a new PE Plus dilatation
catheter (10 cm in length, 10 mm in diameter) (USCI, CR.
Bard, Inc), the sheath can be advanced directly over the inflated balloon (Fig 4), which further reduces the time required
to perform the procedure. With these modifications, tract
dilatation and placement ofthe 30-F sheath can be achieved
in 20 minutes in most patients.
Once the 30-F sheath is in place, 40 mg of Lasix is administered intravenously to help clear clots from the collecting system more rapidly.
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^^nder local anesthesia and fluoroscopic guidance, can
1^ "gauge trocar needle is introduced into the intrarenal col'ng system via a preselected infundibulum. Approach
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Fig 1
Radiology special procedures suite equipped with high-resolution C-arm fluoroscopy unit (C). X-ray tube (X) and control pedals (P) are coveredd witti
plastic bags.

The urologist then introduces the nephroscope into the collecting system through the 30-F sheath. Fluoroscopy is complementary to endoscopy, especially when the calculus is
covered with fresh clots (Fig 5). Calculi up to 1.3 cm in size
can be removed without fragmentation. An ultrasonic lithotriptor is used to fragment larger calculi and staghorn calculi
before they are extracted. Two or more procedures are required for complete removal of most staghorn calculi.
Following extraction ofthe calculus, the sheath is left in place
for about ten minutes with no manipulation, which has considerably decreased bleeding from the tract. During this time,
radiographs are obtained before and after injecting contrast
agent through the retrograde stent to look for retained
fragments of calculus or evidence of perforation of the upper collecting system.
A soft catheter (6.5-F) is passed over the anchor wire and
left in the distal ureter as a temporary stent in all patients
in whom fragmentation of the calculus was necessary and
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in those in whom perforation of the renal pelvis or
ureteropelvic junction occurred. A 24-F Foley catheter or
Malecot catheter is left in the renal pelvis for drainage in all
patients. The position of the catheter in the renal pelvic is
confirmed by injecting contrast agent through the retrograde
ureteric stent or the drainage catheter itself. Irrigation ofthe
renal pelvis through the drainage catheter is performed until the returning fluid is clear of clots. Catheters are anchored
to the skin with 2-0 silk sutures. The retrograde ureteric stent
and the Foley catheter from the bladder are removed after
the procedure. The average time to complete the procedure
is two and one-half hours.

A nephrostogram, including a scout radiograph, is obtained
after 48 hours to determine if the collecting system is cle^
of clots and there is good drainage of contrast agent into tne
bladder without extravasation. When these conditions 3<
met, the nephrostomy tube and the ureteric stent are <^ '
moved, and the patient is discharged the next day. ^ '
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bleeding, which resulted in termination of the procedure
(n = 3).

J liable to keep the drainage catheter and the ureteric stent
^ nlace until no clots exist in the upper collecting system,
extravasation of contrast material is evident, and contrast
'^gent can pass freely down the ureter.

The most common significant complications were bleeding
and sepsis. Hemorrhage requiring transfusion was reported
in 57o of patients. One patient required an emergency open
pyelolithotomy to control hemorrhage. Another patient
underwent successful transcatheter embolization of false
aneurysm for bleeding. Temperature elevation that prolonged
the hospital stay was reported in 3% of patients. Multiple
pulmonary emboli were detected in one patient during
recovery. Perforation ofthe renal collecting system was noted
in two patients on the follow-up nephrostogram. Also of note,
an ileus pattern in a significant number of patients was
observed on the supine nephrostogram.

Results
yye reviewed the records of 121 patients (75 men and 46
vvomen who ranged in age from 26 to 83 years [mean 47])
^ho had undergone PCNL between November, 1982 and
December, 1984. The procedure was successful in 106 of
these patients (88%). The average length of hospital stay was
6.7 days.
In 15 patients, PCNL was unsuccessful due to failure to place
the nephrostomy tube (n =4); failure to visualize the calculus
endoscopically (stones with little or no calcium could not
be seen under fluoroscopy) (n = 3); accidental pulling and
displacement ofthe guidewire and the sheath, which resulted
in termination of the procedure (n = 5); and excessive

Discussion
Our overall success rate of 88% compares favorably with
the reported results of other large series (3-6). Likewise, the

Fig 2
''Mient positioned under fluoroscopy tube (head to left), ready for nephrostomy-tract preparation. Note plastic draping and drainage device (arrows).
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Fig 3
Sequential films demonstrate establishment of nephrostomy and subsequent dilatation of nephrostomy
tract using balloon dilatation catheter (steps g and h).

Fig 4
Sheath (30-F Teflon) is advanced
directly over balloon dilatation
catheter.
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length of hospital stay and the types and frequency of complications are comparable to those reported. Increased experience and improved technique raised the success rate in
the last 60 patients in our study to 90%. With further refinements and careful patient selection, we feel that a 95% success rate is achievable. A significant cost saving is achieved
when the number of days of hospitalization is reduced.
Another significant factor is the fast recovery after the procedure and the return to normal activity: this ranges from
three to ten days depending on the patient's occupation.
This procedure is reliably successful, safe, and cost-effective.
In the current medical economic setting, it is clear that PCNL
is an attractive alternative to open pyelolithotomy.
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Fig 5
Clot-covered renal calculus in nephroscopy forceps.
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